Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 1 board, counting each seat separately. Longest: Ovid Therapeutics Inc., 3 years.
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Ovid Therapeutics Inc. July 10, 202575.6%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Apr 7, 2026 | Ovid Therapeutics Inc. | Grant or award | +17,578 | $2.56 | $45,000 |
| Mar 5, 2026 | Alnylam Pharmaceuticals Inc. | Open-market sale | −124 | $321.81 | $39,904 |
| Mar 5, 2026 | Alnylam Pharmaceuticals Inc. | Open-market sale | −233 | $323.25 | $75,317 |
| Mar 5, 2026 | Alnylam Pharmaceuticals Inc. | Open-market sale | −148 | $324.60 | $48,041 |
| Mar 5, 2026 | Alnylam Pharmaceuticals Inc. | Open-market sale | −153 | $326.24 | $49,915 |
| Mar 4, 2026 | Alnylam Pharmaceuticals Inc. | Open-market sale | −29 | $319.03 | $9,252 |
| Mar 4, 2026 | Alnylam Pharmaceuticals Inc. | Open-market sale | −28 | $320.01 | $8,960 |
| Mar 4, 2026 | Alnylam Pharmaceuticals Inc. | Open-market sale | −59 | $320.81 | $18,928 |
| Mar 4, 2026 | Alnylam Pharmaceuticals Inc. | Open-market sale | −79 | $321.82 | $25,424 |
| Mar 4, 2026 | Alnylam Pharmaceuticals Inc. | Open-market sale | −96 | $323.01 | $31,009 |
| Mar 4, 2026 | Alnylam Pharmaceuticals Inc. | Open-market sale | −210 | $323.84 | $68,006 |
| Mar 4, 2026 | Alnylam Pharmaceuticals Inc. | Open-market sale | −75 | $324.88 | $24,366 |
| Mar 4, 2026 | Alnylam Pharmaceuticals Inc. | Open-market sale | −57 | $325.67 | $18,563 |
| Mar 3, 2026 | Alnylam Pharmaceuticals Inc. | Open-market sale | −289 | $316.55 | $91,483 |
| Mar 3, 2026 | Alnylam Pharmaceuticals Inc. | Open-market sale | −282 | $318.62 | $89,851 |
Questions about Kevin Joseph Fitzgerald
What boards is Kevin Joseph Fitzgerald on?
Kevin Joseph Fitzgerald sits on the board of Ovid Therapeutics Inc.
How long has Kevin Joseph Fitzgerald served on boards?
Our records show at least 4 years of board service across 1 board, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.